(Q44553386)

4 December 2017

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme (English)

1 reference

4 December 2017

0 references

3

1 reference

4 December 2017

Younis N

1

1 reference

PubMed ID

12925058

4 December 2017

Broadbent DM

series ordinal

2

1 reference

PubMed ID

12925058

4 December 2017

Vora JP

series ordinal

4

1 reference

4 December 2017

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

20

1 reference

4 December 2017

9

1 reference

4 December 2017

758-765

1 reference

Blind and partial sight registration in Avon

4 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Cost effectiveness analysis of screening for sight threatening diabetic eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Active prevention in diabetic eye disease. A 4-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Preservation of sight in diabetes: developing a national risk reduction programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01035.X

10.1046/J.1464-5491.2003.01035.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12925058